Tag: larger
Akebia crashes on vadadustat flop in larger anemia indication. Will AZ,...
What was previously expected to be a three-way battle in the novel HIF-PHI renal anemia drug class now has one man down. Akebia Therapeutics has...
Gilead fails to overturn $752M CAR-T patent verdict. Will BMS win...
Bristol Myers Squibb and Gilead Sciences have been locked in a CAR-T patent fight, with BMS scoring a lucrative victory following a trial late last year. Now,...